Krebs Biochemicals and Industries Ltd
KREBSBIOKrebs Biochemicals and Industries Ltd
KREBSBIO
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -6.33 | 4.54 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 40.05 | 4.70 | 0.78% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Krebs Biochemicals and Industries Limited is engaged in the business of manufacture of active pharmaceutical ingredients. The Company is producing a number of pain killers, anti-asthmatic and anti-human immunodeficiency virus (HIV) drugs.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 36.26 | 3.88 | 3.65 | 34.13 | 48.20 | 33.78 | 54.32 | 60.86 | 52.75 | 52.60 | ||||||||||
Raw Materials | 0.00 | 1.77 | 1.34 | 17.12 | 20.99 | 19.18 | 25.62 | 46.18 | 19.81 | 64.20 | ||||||||||
| Power & Fuel Cost | 0.28 | 2.87 | 0.70 | 8.62 | 11.70 | 10.28 | 15.91 | 22.23 | 14.80 | |||||||||||
| Employee Cost | 1.86 | 5.67 | 5.63 | 11.49 | 14.41 | 14.56 | 15.30 | 14.96 | 15.54 | |||||||||||
| Selling & Administrative Expenses | 0.92 | 3.13 | 2.52 | 3.43 | 3.83 | 4.01 | 3.39 | 6.11 | 4.57 | |||||||||||
| Operating & Other expenses | 35.14 | 1.52 | 1.78 | 1.98 | 6.59 | 3.94 | 11.05 | 4.22 | 13.20 | |||||||||||
EBITDA | -1.94 | -11.08 | -8.32 | -8.51 | -9.32 | -18.19 | -16.95 | -32.84 | -15.17 | -11.60 | ||||||||||
| Depreciation/Amortization | 1.87 | 4.49 | 4.23 | 4.15 | 4.40 | 4.68 | 5.12 | 6.30 | 6.56 | 6.51 | ||||||||||
| PBIT | -3.81 | -15.57 | -12.55 | -12.66 | -13.72 | -22.87 | -22.07 | -39.14 | -21.73 | -18.11 | ||||||||||
| Interest & Other Items | 4.03 | 0.74 | 3.49 | 5.17 | 6.29 | 6.00 | 6.28 | 5.39 | 2.97 | 3.77 | ||||||||||
| PBT | -7.84 | -16.31 | -16.04 | -17.83 | -20.01 | -28.87 | -28.35 | -44.53 | -24.70 | -21.88 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Net Income | -7.84 | -16.31 | -16.04 | -17.83 | -20.01 | -28.87 | -28.35 | -44.53 | -24.70 | -21.88 | ||||||||||
| EPS | -7.96 | -13.95 | -11.56 | -12.53 | -12.97 | -16.67 | -15.07 | -21.63 | -11.46 | -10.15 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Krebs Biochemicals and Industries Ltd | -5.61 | 4.54 | — |
| Sun Pharmaceutical Industries Ltd | 32.45 | 4.64 | 1.00% |
| Cipla Ltd | 34.76 | 4.11 | 0.70% |
| Dr Reddy's Laboratories Ltd | 20.93 | 4.05 | 0.71% |
Price Comparison
Compare KREBSBIO with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
KREBSBIO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Vesuvius India Ltd leads losers in ‘B’ group
6 months ago•Business Standard
5Paisa Capital Ltd leads gainers in ‘B’ group
1 year ago•Business Standard
Krebs Biochemicals & Industries reports standalone net loss of Rs 11.31 crore in the March 2022 quarter
1 year ago•Business Standard
Times Guaranty Ltd leads gainers in ‘B’ group
1 year ago•Business Standard
News Video
Krebs Biochemicals Share News : जानें आज Stock में क्यूं दिखाई दे सकती है तेजी? | CNBC Awaaz
1 year ago•CNBC Awaaz
Krebs Biochemicals & Industries board nods allotment of Rs100cr RNNCPS to IPCA Labs
1 year ago•India Infoline
Krebs Biochemicals & Industries reports standalone net loss of Rs 10.85 crore in the September 2021 quarter
1 year ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 9.1%, vs industry avg of 8.45%
Constant Market Share
Over the last 5 years, market share stayed at 0.02%